ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

KNSA Kiniksa Pharmaceuticals Ltd

19,01
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:00
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 0
Prix Achat 17,49
Prix Vente 19,65
Actualités -
Maximum Haut

Bas
13,55

Sur 52 semaines

Haut
22,10

Minimum Bas
Nom Action Symbole Action Marché Type
Kiniksa Pharmaceuticals Ltd KNSA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 19,01 10:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
19,01
Transactions Totales Volume échangé Volume en moyenne Sur 52 semaines
0 0 - 13,55 - 22,10
Dernière Transaction Type Quantités échangées Prix transaction Devise
- 0 US$ 19,01 USD

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
1,34B 70,62M - 270,26M 14,08M 0,20 95,34
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action Kiniksa Pharmaceuticals

Date Heure Source Titre
29/5/202423:19Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
07/5/202422:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at Bank of America..
23/4/202413:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial..
16/4/202422:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report First Quarter 2024..
02/4/202413:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Announces Development Indication for..
05/3/202422:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
29/2/202422:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
28/2/202413:35Edgar (US Regulatory)Form 8-K - Current report
28/2/202413:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year..
27/2/202423:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securities

Forum Action Kiniksa Pharmaceuticals

Aucune Discussion TrouvéeAjouter une Discussion

Historiques Kiniksa Pharmaceuticals Ltd

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine19,2119,2118,325918,87368 890-0,20-1,04%
1 mois20,1420,51518,325919,52288 134-1,13-5,61%
3 mois20,7720,9116,5618,97362 586-1,76-8,47%
6 mois16,6522,1016,4718,98408 1152,3614,17%
1 an14,4922,1013,5517,76425 1484,5231,19%
3 ans13,2022,107,3614,37393 1715,8144,02%
5 ans15,2333,005,0115,38359 6933,7824,82%